Silver Book Fact

The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.

Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. May 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
May 2011
Authors
Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • An estimated 424,801 more visually impaired and blind individuals live in nursing homes than would be expected if they had normal vision.  
  • Close to 2.3 million Americans age 40 and older have glaucoma–1.9% of the 40 and older population.  
  • One study reported emotional distress scores in age-related macular degeneration (AMD) patients comparable to scores of individuals with serious illnesses such as melanoma and HIV.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using outpatient services was $276. The average cost per patient 54 years and older was $254.  
  • Age-related eye diseases are the primary causes of vision impairment and blindness in the U.S.